Author

Alan R. Olzinski

GlaxoSmithKline (United States)ORCID 0009-0002-2193-7073Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Anna Zacco· 1 shared Brian G. LawhorniD· 1 shared Carl A. BrooksiD· 1 shared Christine G. Schnackenberg· 1 shared Christine Y. Ivashchenko· 1 shared Christopher T Louer· 1 shared Daniel T. Sweet· 1 shared Elizabeth Davenport· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Anna Zacco

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A phenotypic screen identified KEAP1-kelch domain blockade as a mechanism to restore cardiac function in the setting of chronic severe hemodynamic stress

John J. Upson, Christine G. Schnackenberg, Brian G. Lawhorn, Quanhai Chen, Daniel T. Sweet, Thimmaiah P. Chendrimada, Carl A. Brooks, Mark E. Burgert, Christopher T Louer, Anna Zacco, Ian Moench, Jonathan B. Basilla, Joseph G. Boyer, Christine Y. Ivashchenko, Sharada Manns, , John R. Toomey

A gene expression-based screen in iPSC-CMs identified KEAP1-kelch domain blockers as effective in restoring cardiac function under chronic hemodynamic stress.

bioRxiv · Sep 24, 2025 · PreprintMolecular Biology